What is the current Catalent market capitalization?
The current market capitalization of Catalent is 9.89 B USD.
Catalent Market capitalization 2024
Catalent Market capitalization
9.89 B USD
Catalent Dividend yield
Ticker
CTLT
ISIN
US1488061029
WKN
A112H2
In 2024, Catalent's market cap stood at 9.89 B USD, a 40.57% increase from the 7.04 B USD market cap in the previous year.
The Catalent Market capitalization history
| YEAR | REVENUE (undefined USD) | GROSS MARGIN (%) | NET INCOME (undefined USD) |
|---|---|---|---|
| 2029e | 6.5 | 16,00 | 708.86 |
| 2028e | 5.97 | 17,42 | 563.03 |
| 2027e | 5.5 | 18,91 | 458.73 |
| 2026e | 5.04 | 20,64 | 335.29 |
| 2025e | 4.69 | 22,17 | 213.33 |
| 2024e | 4.41 | 23,57 | 47.05 |
| 2023 | 4.26 | 24,40 | -256 |
| 2022 | 4.8 | 33,61 | 483 |
| 2021 | 4 | 33,82 | 529 |
| 2020 | 3.09 | 31,78 | 173 |
| 2019 | 2.52 | 31,97 | 137.4 |
| 2018 | 2.46 | 30,55 | 83.6 |
| 2017 | 2.08 | 31,54 | 109.8 |
| 2016 | 1.85 | 31,79 | 111.5 |
| 2015 | 1.83 | 33,61 | 212.2 |
| 2014 | 1.83 | 32,75 | 16.2 |
| 2013 | 1.8 | 31,58 | -49.6 |
| 2012 | 1.69 | 32,96 | -24.4 |
| 2011 | 1.53 | 32,78 | -54 |
| 2010 | 1.48 | 29,78 | -289.6 |
| 2009 | 1.4 | 27,22 | -308.1 |
Catalent Aktienanalyse
What does Catalent do?
Catalent Inc is a global leader in advanced active ingredients and medical products, as well as solutions for drug development and manufacturing. The company was founded in 1933 by the Schering brothers in the USA and has become one of the preferred partners in the pharmaceutical industry due to its innovation, flexibility, and reliability. Catalent's business model is based on providing high-quality services and products that contribute to improving human health. The company offers a wide range of solutions, from active ingredient development to drug formulation and manufacturing, clinical trials, and product packaging. Through this comprehensive offering, Catalent helps its customers accelerate their drug development and product launch. The company is divided into different business sectors with specialized solutions, including the manufacturing of biopharmaceuticals such as antibodies, cell therapies, and vaccines, as well as medical devices, active ingredient manufacturing, and pharmaceutical development and manufacturing. Catalent's services also include active ingredient development, assisting customers in all stages of drug development from identifying new active ingredients to optimizing production processes. The company specializes in formulating drugs into suitable delivery forms that ensure safe and effective use, offering a variety of oral, inhalable, and parenteral formulations. Catalent also provides clinical trials, testing the efficacy and safety of drugs in clinical trials. The company has state-of-the-art facilities and expertise to professionally and successfully support its customers in conducting clinical studies. Additionally, Catalent offers a wide range of packaging solutions, including glass bottles, plastic containers, aluminum tubes, and the finishing and packaging of finished drugs. The company has advanced production systems that enable quick and flexible packaging production in any desired size and shape. Overall, Catalent provides its customers with a comprehensive range of services and products that enable fast and effective drug development and market launch. The company's strong innovation and diverse range of expertise make it a preferred partner in the pharmaceutical industry. Catalent ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Catalent's Market Capitalization
Catalent's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Catalent's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Catalent's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Catalent’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Catalent Stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Catalent.
How has the market capitalization of Catalent developed in recent years?
The market capitalization of Catalent has increased/decreased by 40.57% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Catalent?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Catalent?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Catalent have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Catalent pay?
Over the past 12 months, Catalent paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Catalent is expected to pay a dividend of 0 USD.
What is the dividend yield of Catalent?
The current dividend yield of Catalent is .
When does Catalent pay dividends?
Catalent pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Catalent?
Catalent paid dividends every year for the past 0 years.
What is the dividend of Catalent?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Catalent located?
Catalent is assigned to the 'Health' sector.
Wann musste ich die Aktien von Catalent kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Catalent from 5/24/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 5/24/2024.
When did Catalent pay the last dividend?
The last dividend was paid out on 5/24/2024.
What was the dividend of Catalent in the year 2023?
In the year 2023, Catalent distributed 0 USD as dividends.
In which currency does Catalent pay out the dividend?
The dividends of Catalent are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Catalent stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Catalent
Our stock analysis for Catalent Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Catalent Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
